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Abstract
Background: Renal impairment is one of the predictors of mortality in cardiac surgery. Usually a
binarized value of serum creatinine is used to assess the renal function in risk models. Creatinine
clearance can be easily estimated by the Cockcroft and Gault equation from serum creatinine,
gender, age and body weight. In this work we examine whether this estimation of the glomerular
filtration rate can advantageously replace the serum creatinine in the EuroSCORE preoperative risk
assessment.
Methods: In a group of 8138 patients out of a total of 11878 patients, who underwent cardiac
surgery in our hospital between January 1996 and July 2002, the 18 standard EuroSCORE
parameters could retrospectively be determined and logistic regression analysis performed. In all
patients scored, creatinine clearance was calculated according to Cockcroft and Gault. The
relationship between the predicted and observed 30-days mortality was evaluated in systematically
selected intervals of creatinine clearance and significance values computed by employing Monte
Carlo methods. Afterwards, risk scoring was performed using a continuous or a categorical value
of creatinine clearance instead of serum creatinine. The predictive ability of several risk score
models and the individual contribution of their predictor variables were studied using ROC curve
analysis.
Results: The comparison between the expected and observed 30-days mortalities, which were
determined in different intervals of creatinine clearance, revealed the best threshold value of 55 ml/
min. A significantly higher 30-days mortality was observed below this threshold and vice versa (both
with p < 0.001). The local adaptation of the EuroSCORE is better than the standard EuroSCORE
and was further improved by replacing serum creatinine (SC) by creatinine clearance (CC).
Differential ROC analysis revealed that CC is superior to SC in providing predictive power within
the logistic regression. Variable rank comparison identified CC as the best single variable predictor,
even better than the variable age, former number 1, and SC, previously number 9 in the standard
set of EuroSCORE variables.
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Conclusion: The renal function is an important determinant of mortality in heart surgery. This
risk factor is not well captured in the standard EuroSCORE risk evaluation system. Our study
shows that creatinine clearance, calculated according to the Cockcroft and Gault equation, should
be applied to estimate the preoperative renal function instead of serum creatinine. This predictor
variable replacement gains a significant improvement in the predictive accuracy of the scoring
model.
Background
Several models for preoperative risk assessment in cardiac
surgery were introduced in the past 15 years, all of which
considered the renal function as one of the predictors of
mortality. The following criteria were used to estimate the
renal function: acute renal failure, necessity of dialysis,
categorical serum creatinine value with the threshold set
in the interval between 1.6 and 2.3 mg/dl (140 and 200
µmol/l) [1].
The European System for Cardiac Operative Risk Evalua-
tion (EuroSCORE) is one of the established risk score sys-
tems in Europe [2–4]. In Germany, the EuroSCORE is
applied as a nation-wide tool for the risk adjustment of
30-days mortality in cardiac surgery quality control. This
scoring system is based on a logistic regression model for
mortality and considers all adult cardiac surgery proce-
dures within a defined 30-days post-operative time inter-
val. The impaired renal function is included in this score
system as one of 18 independent predictors by testing on
serum creatinine values above threshold 200 µmol/l (see
Table 4). According to the standard, so-called "simple
additive" EuroSCORE model, an integer number called
weight is assigned to each risk parameter present in the
scored patient. The individual weights are added to give
the expected risk score of death. The EuroSCORE value
usually lies between 0 and 20. One main attraction of this
model is its simplicity and its ease of usage and of expla-
nation for people without statistical training. The newer,
published version of the EuroSCORE, also called the "full
logistic" EuroSCORE, assigns a weight of continuous
value to each risk factor. These values can enter directly
the probability calculation of the mean multicenter mor-
tality risk.
In 1976, Cockcroft and Gault introduced an equation to
estimate the glomerular filtration rate from the serum cre-
atinine value, also considering such variables as age, gen-
der and body weight [5]. We have studied a large group of
our patients with the aim of establishing whether it is
appropriate to replace serum creatinine in the Euro-
SCORE based preoperative risk estimation by creatinine
clearance, calculated according to the Cockcroft-Gault
formula.
Patients and Methods
A total of 11878 patients underwent cardiac surgery in our
hospital in the period between January 1996 and July
2002. The 18 EuroSCORE risk variables could retrospec-
tively be determined in a group of 8138 patients. In our
institute, the postoperative course is systematically
checked six months after surgery. Thanks to this approach,
the 30-days mortality rate could easily be determined. In
all our patients scored, creatinine clearance was calculated
according to Cockcroft and Gault. The following equation
was used for men:
The proportion of muscle mass on body weight is rela-
tively lower in women than in men. Therefore, the calcu-
lated value of creatinine clearance was multiplied by the
factor of 0.85 in female patients. Although serum creati-
nine is one of the dichotomous variables in the Euro-
SCORE it is impossible to linearly transform this to
Equation (1).
Earlier studies, comparing our patient population with
the original EuroSCORE study, revealed, on the one hand,
that our group of patients exhibited a risk profile which
was shifted towards higher risk values and, on the other
hand, significantly lower mortality in our patients (see
Table 1). Missing value analysis revealed two anomalies of
the data set: the mortality was significantly higher when
the variable "chronic pulmonary disease" or "neurologi-
cal dysfunction" was missing and therefore patient
excluded from this study. But it turned out that this is due
to the incomplete data collection in cases of very emergent
operations. In other words the present data set underrep-
resents the small group of emergency operations (preva-
lence 1.6% instead of 3.6% total).
We have developed several approaches based on the
standard EuroSCORE model with the aim of establishing
our own institutional risk scoring system. All our models
used the 18 standard preoperative EuroSCORE risk varia-
bles. The added weights, which were assigned to the risk
factors present, gave the final predictive risk value. In the
first calibration step, the simple additive model was
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adjusted to the observed institutional mortality by regres-
sion analysis. In this way, the individual risk, expressed as
expected mortality (EM), could be determined for each
patient as the death probability. For all patients, this prob-
ability was in the range of 0.002 to 0.1.
The studied population of 8138 patients was divided into
13 groups on the basis of creatinine clearance (CC) calcu-
lated according to the Cockcroft-Gault formula. In each
group, the sum of the expected mortality (EM) was com-
pared with the sum of the observed mortality (OM). The
difference between EM and OM, the negative residuals,
are sometimes called "net life saved" (NLS) values (partic-
Table 1: Differences between the EuroSCORE and Lahr patient population
A: Preoperative attributes
EuroSCORE Lahr
diabetes mellitus
on insulin 4.0% 10.0%
on oral therapy 8.5% 17.0%
body mass index > 33 5.0% 11.0%
mean age (years) 62.4 65.0
age > 75 years 10.0% 17.0%
B: Risk distribution and mortality
EuroSCORE Lahr
Risk EuroSCORE value Prevalence Mortality Prevalence Mortality
low 0–2 30.6% 0.8% 27.0% 0.34%
medium 3–5 40.4% 3.1% 39.7% 1.4%
high ≥ 6 29.0% 11.0% 31.3% 4.1%
Table 2: Deviations of expected and observed mortality frequencies and their significance for several creatinine clearance intervals.
CC [ml/min] Cases # Cases % OM # EM # NLS (EM-OM) RAMQ (OM/EM) P
CC < 15 35 0.4 % 3 2.33 -0.67 1.29 0.73
15 ≤ CC < 25 94 1.2 % 14 10.17 -3.83 1.38 0.18
25 ≤ CC < 35 284 3.5 % 17 12.76 -4.24 1.33 0.245
35 ≤ CC < 45 623 7.7 % 29 23.49 -5.51 1.23 0.24
45 ≤ CC < 55 1054 13.0 % 43 29.74 -13.26 1.45 0.011
55 ≤ CC < 65 1236 15.2 % 15 27.01 12.01 0.56 0.006
65 ≤ CC < 75 1343 16.5 % 21 23.39 2.39 0.9 0.64
75 ≤ CC < 85 1123 15.1 % 14 17.28 3.28 0.81 0.46
85 ≤ CC < 95 854 10.5 % 11 11.35 0.35 0.97 0.96
95 ≤ CC < 105 525 6.5 % 3 5.77 2.77 0.52 0.24
105 ≤ CC < 115 362 4.4 % 2 4.35 2.35 0.46 0.27
115 ≤ CC < 125 221 2.7 % 1 2.33 1.33 0.43 0.57
125 ≤ CC 384 4.7 % 1 4.31 3.31 0.23 0.07
total 8138 100 % 174 174.34 0.34 1
CC < 55 2091 25.7 % 106 78.55 -27.45 1.35 < 0.001
CC ≥ 55 6047 74.3 % 68 95.79 27.79 0.71 < 0.001
CC: creatinine clearance calculated according to the Cockcroft-Gault formula (see Eq. 1); OM#: number of observed mortalities; EM#: sum of 
expected mortality; NLS: net life saved; RAMQ: risk adjusted mortality quotient.BMC Surgery 2003, 3 http://www.biomedcentral.com/1471-2482/3/4
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ularly in the context of temporal performance evalua-
tions, e.g. "VLAD" [6]). A positive NLS value indicates the
operation results are better than expected. Since the NLS
value scales with the group size, a second invariant meas-
ure, the OM-to-EM ratio, also called the "risk adjusted
mortality quotient" (RAMQ), was determined. A RAMQ
value below one indicate a surgical performance better
than the average.
Due to the low probability of death and the finite group
sizes considerable fluctuations of the NLS and RAMQ val-
ues are encountered. To determine the significance of
deviations, we employed the method of Monte Carlo sim-
ulation in order to gain EM distributions and from there
measurements of significance. Here the null hypothesis is
the correctness of the underlying risk model in all groups
studied. The alternative hypothesis is that the risk model
is incomplete and systematic deviations in the CC groups
are present. We found the latter true and subsequently
determined the most effective binary threshold for the CC
value. By systematic testing (in the obvious range 45–65)
we found the threshold CC<55 ml/min. On the one hand
this aggregation in two groups improves the significance
by increasing the number of observations per group, and
on the other hand, it is in concordance with the spirit of
the EuroSCORE as a simple, easy usable scoring system.
The consequence is the suggestion to modify the Euro-
SCORE system by the replacing serum creatinine value by
the creatinine clearance value in order to better capture
the risk from impaired renal function.
In the next step we analysed the potential improvement of
this step by comparing various logistic risk models using
the measure of the area under the receiver operating char-
acteristic (ROC) curves. (i) The first model studied the
simple additive EuroSCORE model with 18 fixed integer
weights (see Table 4 and http://www.euroscore.org/
euroscore_scoring.htm) calibrated for our data set. (ii)
The second score model examined was the full logistic
EuroSCORE with fixed and continuous weights (see http:/
/www.euroscore.org/logisticEuroSCORE.htm). (iii) In the
third model, the weighted values of all 18 EuroSCORE
risk factors were directly determined by the logistic regres-
sion fit. (iv) In the fourth model, serum creatinine was
replaced by a continuous CC value as a risk variable char-
acterising the renal function. (v)  This procedure was
repeated in the fifth model, however, instead of the con-
tinuous CC value the dichotomous value with the thresh-
old CC<55 ml/min was used.
Improving mature risk models is inherently difficult and
changes in ROC area are difficult to judge since the differ-
ences are often smaller than the computed standard devi-
ations. Therefore we examined the predictive power of all
18 EuroSCORE variables in addition to the CC variable by
comparing logistic regression models. The first set of
models capture the predictive power contribution of a var-
iable by contrasting the full EuroSCORE (Type (iii)  in
Table 3) and the reduced model, generated by leaving out
the considered variable. The ROC area reduction is com-
puted and the rank order determined. The second set of
models examines the single predictor ability by comput-
ing and ranking the gain in ROC area compared to the
uninformed dummy predictor with area = 0.5. The rank-
ing results allow to judge the newly suggested predictor
variable in comparison to the widely established Euro-
SCORE variable set.
Results
Figure 1 shows the distribution of patients scored (with
model 1 in Table 3), as well as the distribution of
observed (OM) and expected mortalities (EM) for several
CC intervals. The maximum EM values occurred at lower
CC values than (or left of) the cases curve maximum. This
means that the EuroSCORE did identify low CC values as
being associated with a higher risk. Nevertheless, the risk
was underestimated, which becomes apparent at the
excess of the observed mortality curve (OM > EM) for all
CC intervals below 55 and the clear reverse (OM < EM) for
all higher intervals. The differences between the observed
and expected mortalities were significant in two groups:
45≤CC<55 with p = 0.011 and 55≤CC<65 with p = 0.006
found by Monte-Carlo simulated mixture of individual
Table 3: Predictive ability of the EuroSCORE risk score model and comparision with suggested modified systems.
Model Area under the ROC curve SD
(i) original EuroSCORE weights, „simple additive" version (locally calibrated) 0.753 0.018
(ii) original EuroSCORE weights, „logistic" version (locally calibrated) 0.757 0.018
(iii) all EuroSCORE variables with weights from institute specific regression 0.776 0.018
(iv) same as model (iii) but CC as continuous value substituted for serum creatinine 0.786 0.017
(v) same as model (iii) but CC as binarized value (threshold >55 ml/min) substituted for 
serum creatinine
0.787 0.017
CC: creatinine clearance calculated according to the Cockcroft-Gault formulaBMC Surgery 2003, 3 http://www.biomedcentral.com/1471-2482/3/4
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expected risks (Table 2). After the formation of two aggre-
gate groups with the systematically identified threshold
CC<55 ml/min the significance became even more pro-
nounced with p < 0.001 (see Table 2 and Figure 2).
The predictive ability of the CC-modified EuroSCORE risk
score is better than the predictive accuracy of the original
EuroSCORE models (i+ii) and the locally adapted logistic
regression (iii). The replacement of serum creatinine by
creatinine clearance either as a continuous (iv) or
categorical value (v), both improve the predictive power
of the EuroSCORE models. As the ROC area results in
Table 3 show, categorical CC model (v) is best (0.776 s.d.
0.018), closely followed by the continuous CC model (iv).
Figure 3 displays the results of the individual contribution
of the 18 well established predictors to the predictive abil-
ity of the EuroSCORE. The marginal ROC area contribu-
tions and their rank number is listed for the set removal
and the single predictor case. The binarized and the con-
tinuous CC value gain both the 5th rank for replacing
serum creatinine and the 1st rank as single variable predic-
tor, while the SC variable holds the 14th and 9th rank only.
Discussion
In the Framingham Heart Study performed on 6233 sub-
jects (mean age 54 years, 54% females), 8% of women
and 8.7% of men exhibited mild renal insufficiency,
which was defined according to the serum creatinine
value (120 to 256 µmol/l, i.e., 1,4 to 3,0 mg/dl in women
and 136 to 265 µmol/l, i.e., 1,5 to 3,0 mg/dl in men) [7].
The data analysis of 18790 patients in the HOT (Hyper-
tension Optimal Treatment) Study revealed that the
impaired renal function was a predictor of increased car-
diovascular morbidity and mortality and that patients suf-
fering from renal failure exhibited a higher cardiovascular
risk than patients with an intact renal function [8]. In
patients with chronic heart failure, the renal function is a
prognostic risk value [9,10] which can be regarded as a
predictor of mortality in this patient group [11]. Multiple
models for preoperative risk evaluation in patients under-
going heart surgery also confirmed the significance of the
renal function as a predictor of mortality. In these models,
acute renal failure, the necessity of dialysis and serum
creatinine, in form of a categorical value, were applied as
risk criteria [1].
Table 4: EuroSCORE model and ist scoring weights; standard "simple additive" version, as http://www.euroscore.org and Tab. 3(i).
Patient-related factors Score
Age (per 5 years or part thereof over 60 years) 1
Sex female 1
Chronic pulmonary disease longterm use of bronchodilators or steroids for lung disease 1
Extracardiac arteriopathy any one or more of the following: claudication, carotid occlusion or >50% stenosis, previous or 
planned intervention on the abdominal aorta, limb arteries or carotids
2
Neurological dysfunction disease severely affecting ambulation or day-to-day functioning 2
Previous cardiac surgery requiring opening of the pericardium 3
Serum creatinine >200 m micromol/L preoperatively 2
Active endocarditis patient still under antibiotic treatment for endocarditis at the time of surgery 3
Critical preoperative state any one or more of the following: ventricular tachycardia or fibrillation or aborted sudden death, 
preoperative cardiac massage, preoperative ventilation before arrival in the anaesthetic room, 
preoperative inotropic support, intraaortic balloon counterpulsation or preoperative acute renal 
failure (anuria or oliguria <10 ml/hour)
3
Cardiac-related factors Score
Unstable angina rest angina requiring iv nitrates until arrival in the anaesthetic room 2
LV dysfunction moderate or LVEF30–50% 1
poor or LVEF <30 3
Recent myocardial infarct (<90 days) 2
Pulmonary hypertension Systolic PA pressure>60 mmHg 2
Operation-related factors Score
Emergency carried out on referral before the beginning of the next working day 2
Other than isolated CABG major cardiac procedure other than or in addition to CABG 2
Surgery on thoracic aorta for disorder of ascending, arch or descending aorta 3
Postinfarct septal rupture 4BMC Surgery 2003, 3 http://www.biomedcentral.com/1471-2482/3/4
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The serum creatinine level is influenced by many factors
which are independent of the glomerular filtration rate:
tubular secretion and reabsorption, endogenous produc-
tion, variable intake, extrarenal elimination and interfer-
ence, caused by the laboratory diagnostic techniques and
medicaments used [12,13]. Since the assessment of the
renal function, based on the determination of serum cre-
atinine, is associated with several limitations [13,14] and
the measurement of creatinine clearance by urine
collection is rather time-consuming, several formulas esti-
mating the renal function from serum creatinine, body
weight, age and sex, as well as ethnic features, have been
developed. All these formulas exhibit certain limitations.
The most commonly used equation for estimating creati-
nine clearance, e.g., in the Medicare programme and in
the transplantation waiting lists in the USA [15], is the
Cockcroft-Gault formula. Although this formula also does
not provide absolutely accurate results (e.g., in elderly
patients) and it may over- or underestimate the true renal
function [12,16–19], several studies on cardiac insuffi-
ciency and renal impairment have shown a good correla-
tion between the creatinine clearance values calculated
according to Cockcroft and Gault and the measured
glomerular filtration rate [20–24]. Because of this broad
acceptance of the Cockcroft-Gault formula, we have
decided to use it in our model.
The initial steps in our present study concentrated on the
proper selection of a threshold creatinine clearance value.
It was apparent that in all patient groups with a CC value
lower than 55 ml/min the observed mortalities were
higher than the ones predicted by the standard
Figure 1
Distribution of cases, observed and expected mortalities in 13 creatinine clearance intervals (numbers in percent of total, see 
Table 2; underlying risk model type (i) in Table 3).
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EuroSCORE model. This indicates a poor modelling of
the renal impairment variable in the EuroSCORE model,
which is defined by a binary serum creatinine variable, i.e.
SC level above 200 µmol/l (Table 4).
The determined CC threshold of 55 ml/min is in accord-
ance with many findings of other authors. The large HOT
Study defined a CC value of 60 ml/min as a criterion for
the impaired renal function [8]. Hillege and co-workers
[11] divided their population of 1906 patients suffering
from chronic heart failure into four groups according to
the CC values estimated with the Cockcroft-Gault for-
mula. The following intervals of CC values were used:
<44, 44–58, 59–76 and >76 ml/min. The overall mortality
(calculated according to Kaplan-Meyer) in the four groups
studied was 36.5%, 24.8%, 17.6% and 13.7% whereby
significant differences were determined between the first
two and last two groups.
Because of the differences in the risk profile between the
patient population examined in the EuroSCORE study
and our own (see Table 1), we have developed several
own institutional score models by means of logistic
regression analysis. To be able to secure comparability
with other institutions and because of the broad accept-
ance of the EuroSCORE model, we have used its 18 deter-
minants as the basis of our model as well. The predictive
power of the score model can be improved by readapting
the EuroSCORE regression model to the large patient pop-
ulation in our institution (Table 3). Furthermore, we have
shown that the variable selection of the EuroSCORE can
be significantly improved by better capturing the major
risk factor impaired renal function. We found either the
continuous or the binarized preoperative creatinine
clearance value is an easy to assess measurement which
encoded renal function much better than the binarized
Figure 2
Similar to Table 2, here as bar plot and split in two CC groups with threshold 55 ml/min.
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serum creatinine value as called for in the EuroSCORE
procedure.
We showed this by significance analysis of the binarized
CC<55 value with p < 0.001 using Monte-Carlo methods.
Furthermore we demonstrated the improvement of the
predictive power by calculating the area gain under the
ROC curve. The final experiments examined the individ-
ual contribution of each EuroSCORE variable to the ROC
area. Only one variable ("age") showed a marginal ROC
area contribution (0.0291) larger than one standard devi-
ation of the best ROC value (0.0018). All other 17 well
established predictors would be doubted when judged by
ROC area improvement only. This exhibits the difficulty
of the uncertainty measures (s.d.) of the ROC area in com-
parison to model differences. To circumvent this hurdle
we evaluated the rank ordering of the predictors contribu-
tion. This can be done in two ways: either the marginal
contribution measured by leaving the predictor out of the
regression, or by employing only the isolated predictor.
The resulting numbers and rankings are certainly varying
since in the set of 18 parameter the information is par-
tially provided by other variables.
The rank numbers expose the superiority of the proposed
creatinine clearance value compared to the standard Euro-
SCORE choice. While the serum creatinine variable ranks
number 14, the CC replacement would gain rank 5 within
the (modified) set of EuroSCORE predictors. The reverse
view gives even more favourable figures: the creatinine
clearance value (binary or continuous) surpasses age in
the top rank as a single variable predictor.
Figure 3
Contribution of single predictors of the EuroSCORE measured by change in area under the Receiver Operating Characteristics 
(ROC) curve (times 100) in two ways: The "Leave out Predictor" results show the reduction of ROC area from the full set of 
EuroSCORE variables ROC = 0.776 (model 3 in Table 3). The "Single Predictor" numbers indicate the predictive power of 
each isolated variable (i.e. ROC gain above 0.5, times 100). Furthermore the binarized creatinine clearance variable ("CC<55") 
is added (as a replacement for serum creatinine) and its insertion position in the rank ordering 1..18 indicated by an extra dec-
imal digit (5.0 and 1.0 before 5 and 1 resp.). Note, that in the "Leave out" case the CC-variable reaches the 5th most contribut-
ing predictor and in the single predictor experiment it even outperforms "Age" and gains the top rank. Serum creatinine holds 
only position 14 and 9 respectively.
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The risk model based estimation of the expected mortali-
ties, the grouping (EM) and comparison with the total
observed mortality (OM) by the two parameters, NLS and
RAMQ, represent effective analytical tools in assessing the
potential further influences for mortality (occurrence of
preoperative disease, choice of surgical procedure, etc.).
Using Monte-Carlo methods for testing the significance of
deviations as well as ranking of predictor variable are a
valuable addition to conventional statistical methods.
These analytical methods give us the opportunity to better
study, e.g., the effects of the renal function, diabetes and
body mass index on the outcome of patients undergoing
heart surgery.
On the basis of our results we summarize that the renal
function is an important determinant of 30-days mortal-
ity in cardiac surgery. This risk factor is not well captured
in the standard EuroSCORE model. Creatinine clearance
calculated according to the Cockcroft and Gault equation
should be considered in the preoperative assessment of
the renal function instead of serum creatinine. This proce-
dure results in a significant improvement of the risk
estimation.
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